Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Designs and manufactures molecular spectroscopy optical sensors.
Year Established: | 2003 |
Funding: | 19.2 |
Address: | Morrisville, NC 27560 |
Telephone: | |
Mobile: | |
Fax: | |
Mail: | info@centice.com |
Company URL: | http://www.centice.com |
Centice Corporation helps people do amazing things – and we want to enable our employees to do amazing things too. We are a dynamic fast-paced organization providing an environment of individual responsibility with a problem-solving focus.
We are seeking individuals who embrace the challenge of bringing innovative products to market and building a dynamic and enduring company. Centice looks for talent who exude excellence and enthusiasm to adjoin their valuable expertise to our high quality team.
To apply please paste your resume in the message field of your e-mail. In the subject line of the e-mail please include your name and the position you are applying for. Apply Now.
In addition to a dynamic work environment we also offer a competitive compensation and benefits package. Click here for more information.
“I joined Centice because the cutting edge technologies that Centice has been creating to improve the quality and efficiency of dispensed medications strongly appealed to me. The success and reputation of Centice drove me to dedicate my knowledge and experience to the company – I feel privileged to have the opportunity to work for Centice. Furthermore I am excited to work with such enthusiastic collaborative and high-energy teams which was another important factor in deciding to join Centice – to achieve common goals and accomplish my dreams.”
Yuting Qi PhD Research Scientist
Copyright © 2009 Centice. All Rights Reserved. | Home | Contact Us | Terms of Use | Privacy Policy | Site Map
Centice is dedicated to educating the pharmaceutical market and providing a solution to reducing medication errors providing increased productivity and efficiency and offering peace of mind that your patients are receiving the highest quality of care. Talk to our team at any of the following event meetings:
There are no scheduled events at this time please check back with us soon!
For more information please contact Centice Public Relations at (919) 653-0424 or pr@centice.com.
Copyright © 2009 Centice. All Rights Reserved. | Home | Contact Us | Terms of Use | Privacy Policy | Site Map
Centice is dedicated to educating the pharmaceutical market and providing a solution to reducing medication errors providing increased productivity and efficiency and offering peace of mind that your patients are receiving the highest quality of care. Talk to our team at any of the following event meetings:
There are no scheduled events at this time please check back with us soon!
For more information please contact Centice Public Relations at (919) 653-0424 or pr@centice.com.
Copyright © 2009 Centice. All Rights Reserved. | Home | Contact Us | Terms of Use | Privacy Policy | Site Map
There are no scheduled conferences or events at this time please check back with us soon! Thank you.
For more information please contact Centice Public Relations at pr@centice.com
Copyright © 2009 Centice. All Rights Reserved. | Home | Contact Us | Terms of Use | Privacy Policy | Site Map
Centice Corporation the pioneer in drug verification and safety will speak and present on two different technical topics at PittCon Conference and Expo 2010.
Centice Corporation a pioneer in drug verification and safety products announced today that Congressman David Price visited Centice headquarters on January 29th.
Centice Corporation a pioneer in drug verification and safety products has released a new version of PASS Rx with an expanded feature set and drug database.
Centice announced today that it will expand its sales team with two new Sales Directors Doug Williams and Bill Reynolds to exclusively promote and sell the companyâs
PASS Rx® system.
October 21 2009 â Centice Corporation announced today the successful completion of a $6.1 million Series C financing from its existing investors along with a new investor Fulcrum Financial Group LP. The funds will be used to support ongoing commercialization efforts for PASS Rx.
Centice announced today that Arthur Bergens Centice Corporationâs Chief Financial and Operating Officer was named as a 2009 Top CFO by Business Leader Media and BDO Seidman LLP
Centice Corporation a pioneer in drug verification and safety products announced today that David Brady PhD has been honored with an endowed professorship as the Michael J. Fitzpatrick Professor of Engineering.
August 26 2009 â Centice Corporation a pioneer in drug verification and safety products announced today that Arthur Bergens has been promoted to the position of Chief
Operating Officer.
Centice announced today that while published data shows e-prescribing can help reduce the potential for reducing pharmacy errors the PASS Rx system is the first and only product that utilizes patented spectroscopy and machine vision sensor technologies to confirm the accuracy of a retail pharmacyâs dispensed solid dose medications in a matter of seconds.
Centice released a whitepaper today entitled Preliminary Evaluation of a New Product for the Rapid and Accurate Verification of Dispensed Medications in the Retail Pharmacy Environment. The whitepaper highlights product requirements and initial performance data for a prototype version of the companyâs recently introduced PASS Rx system.
Copyright © 2009 Centice. All Rights Reserved. | Home | Contact Us | Terms of Use | Privacy Policy | Site Map
MORRISVILLE NC (February 1 2010) â Centice Corporation a pioneer in drug verification and safety products announced today that it has released a new version of its PASS Rx system. PASS Rx scientifically verifies within a closed pill vial the majority of the oral solid medications to improve the dispense accuracy in pharmacies. PASS Rx is the most reliable solution to allow pharmacies to protect themselves and their patients.
According to a 2006 report from the Institute of Medicine at least 1.5 million Americans are injured by medication errors every year many due to the wrong drug or strength being dispensed. Another study states that about four drug or strength errors occur per day in a pharmacy with a daily volume of 250 prescriptions. Manual verification can be largely subjective; Centice can help.
The new enhancements in Version 3.0 include an increased database size to over two thousand unique medications which equates to more than 20000 NDCs. In addition PASS Rx can now be used to perform accuracy scans for barcode-based verification of non-vial dispensed drugs. Combined these enhancements enable PASS Rx to cover nearly 100% of the workflow in retail and hospital outpatient pharmacies.
After multiple customer focus groups were conducted the new user interface was also improved to provide the pharmacist or technician with easy to understand results on the display. The user interface continues to provide Medi-Span® drug images and descriptions for the added value of visual verification.
Centice Corporation provides its customers with storage and reporting capabilities to enhance quality control in the pharmacy. Anything scanned and/or analyzed through the PASS Rx system is captured for future reporting on how many scripts were filled how many were run through PASS Rx and how many errors have been caught.
Periodic updates are provided remotely so that Centice may provide its customers with the most up-to-date information as drugs are added or removed from the library and for faster customer service.
âWe are thrilled to offer our pharmacy customers an improved solution that will assist them in increasing their quality and efficiency ultimately allowing them to do what they do best spend more time consulting with their patientsâ said Scott Albert Chairman of the Board and Chief Executive Officer of Centice.
Centice founded in 2004 and headquartered in Morrisville NC is commercializing patented and patent-pending computational sensor and machine vision technology. The PASS Rx® pharmaceutical authentication sensor system improves the verification process for dispensed medications thereby improving quality and optimizing workflow in the pharmacy. The company has received venture capital investments from The Aurora Funds Inc. Novak Biddle Venture Partners S-Group Direct Investments Ltd Innovation Ventures LP Fulcrum Financial Group L.P. and other private investors. More information on Centice can be found at www.centice.com.
Centice Public Relations
919.653.0424
pr@centice.com
Copyright © 2009 Centice. All Rights Reserved. | Home | Contact Us | Terms of Use | Privacy Policy | Site Map
Aurora Funds, Inc.,Delaware Innovation Fund (AKA: DIF),Novak Biddle Venture Partners, L.P.,Undisclosed Firm
Proven leadership guides Centice Corporation’s pursuit of innovative products and services
At all levels of our organization, Centice Corporation relies on driven, forward-thinking individuals to define our direction. Discover More… about the leaders who help us realize our vision and achieve success.